The Food and Drug Authority (FDA) has announced the presence of a falsified antimalarial drug, Combiart Tablets (Artemether/Lumefantrine 20/120) on the market.
A statement from the Authority said after its market surveillance found that samples of the drug from the Northern Region did not contain any of the two active pharmaceutical ingredients stated on the label, hence it could be classified as falsified.
Details of the drug are as follows: Batch number: 7225119, Manufacturing date: 03/2021, Expiry date: 02/2024, Manufacturer: Strides Arcolab Ltd. NAFDAC Registration: A4-6700 er/Lumefantrine 20/120) on our market” it added.
The statement asked the public to contact the Authority at www.fdaghana.gov.gh.
Priscilla Nimako, ISD
Leave a Reply